116 related articles for article (PubMed ID: 37838611)
1. A risk stratification system developed to predict contralateral incidental malignant foci in early papillary thyroid carcinoma preoperatively.
Lin P; Liang F; Liao J; Ruan J; Wu H; Han P; Chen R; Luo B; Ouyang N; Huang X
Surgeon; 2024 Apr; 22(2):e79-e86. PubMed ID: 37838611
[TBL] [Abstract][Full Text] [Related]
2. Constructing a nomogram based on the distribution of thyroid nodules and suspicious lateral cervical lymph nodes in fine-needle aspiration biopsies to predict metastasis in papillary thyroid carcinoma.
Liu SQ; Feng JW; Yan ZT; Xing XX; Jiang WY; Jiang Y; Qian F; Xing W
Front Endocrinol (Lausanne); 2023; 14():1242061. PubMed ID: 38089614
[TBL] [Abstract][Full Text] [Related]
3. Preoperative prognostic risk stratification model for papillary thyroid carcinoma based on clinical and ultrasound characteristics.
Shen K; Xiao S; Wu X; Zhang G
Front Endocrinol (Lausanne); 2022; 13():1025739. PubMed ID: 36277684
[TBL] [Abstract][Full Text] [Related]
4. Nomograms to predict ipsilateral and contralateral central lymph node metastasis in clinically lymph node-negative patients with solitary isthmic classic papillary thyroid carcinoma.
Feng JW; Qu Z; Ye J; Hong LZ; Liu SY; Wang F; Jiang Y; Hu J
Surgery; 2021 Dec; 170(6):1670-1679. PubMed ID: 34275617
[TBL] [Abstract][Full Text] [Related]
5. Nomogram for Predicting Central Lymph Node Metastasis in Papillary Thyroid Cancer: A Retrospective Cohort Study of Two Clinical Centers.
Yang Z; Heng Y; Lin J; Lu C; Yu D; Tao L; Cai W
Cancer Res Treat; 2020 Oct; 52(4):1010-1018. PubMed ID: 32599980
[TBL] [Abstract][Full Text] [Related]
6. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
7. Risk factors stratifying malignancy of nodules in contralateral thyroid lobe in patients with pre-operative ultrasound indicated unilateral papillary thyroid carcinoma: A retrospective analysis from single centre.
Lv T; Zhu C; Di Z
Clin Endocrinol (Oxf); 2018 Feb; 88(2):279-284. PubMed ID: 29083503
[TBL] [Abstract][Full Text] [Related]
8. Predicting Factors for Bilaterality in Papillary Thyroid Carcinoma with Tumor Size <4 cm.
Kim SK; Park I; Woo JW; Lee JH; Choe JH; Kim JH; Kim JS
Thyroid; 2017 Feb; 27(2):207-214. PubMed ID: 27750022
[TBL] [Abstract][Full Text] [Related]
9. Thyroid Lobectomy for T1 Papillary Thyroid Carcinoma in Pediatric Patients.
Sudoko CK; Jenks CM; Bauer AJ; Isaza A; Mostoufi-Moab S; Surrey LF; Bhatti TR; Franco A; Adzick NS; Kazahaya K
JAMA Otolaryngol Head Neck Surg; 2021 Nov; 147(11):943-950. PubMed ID: 34554217
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological characteristics including BRAF V600E mutation status and PET/CT findings in papillary thyroid carcinoma.
Choi EK; Chong A; Ha JM; Jung CK; O JH; Kim SH
Clin Endocrinol (Oxf); 2017 Jul; 87(1):73-79. PubMed ID: 28329426
[TBL] [Abstract][Full Text] [Related]
11. Construction of prediction models for determining the risk of lateral lymph node metastasis in patients with thyroid papillary carcinoma based on gender stratification.
Wu WX; Qi GF; Feng JW; Ye J; Hong LZ; Wang F; Liu SY; Jiang Y
Eur Arch Otorhinolaryngol; 2023 May; 280(5):2511-2523. PubMed ID: 36622416
[TBL] [Abstract][Full Text] [Related]
12. Preoperative risk stratification for patients with ≤ 1 cm papillary thyroid carcinomas based on preoperative blood inflammatory markers: construction of a dynamic predictive model.
Zhao L; Hu T; Cai Y; Zhou T; Zhang W; Wu F; Zhang Y; Luo D
Front Endocrinol (Lausanne); 2023; 14():1254124. PubMed ID: 38189045
[TBL] [Abstract][Full Text] [Related]
13. Association between diffuse lymphocytic infiltration and papillary thyroid cancer aggressiveness according to the presence of thyroid peroxidase antibody and BRAF
Lee YK; Park KH; Park SH; Kim KJ; Shin DY; Nam KH; Chung WY; Lee EJ
Head Neck; 2018 Oct; 40(10):2271-2279. PubMed ID: 29935011
[TBL] [Abstract][Full Text] [Related]
14. BRAF V600E Gene Mutation Is Associated With Bilateral Malignancy of Papillary Thyroid Cancer.
Liu Z; Lv T; Xie C; Di Z
Am J Med Sci; 2018 Aug; 356(2):130-134. PubMed ID: 30219154
[TBL] [Abstract][Full Text] [Related]
15. Preoperative prediction of central lymph node metastasis in cN0T1/T2 papillary thyroid carcinoma: A nomogram based on clinical and ultrasound characteristics.
Li J; Sun P; Huang T; Li L; He S; Ai X; Xiao H; Xue G
Eur J Surg Oncol; 2022 Jun; 48(6):1272-1279. PubMed ID: 35414404
[TBL] [Abstract][Full Text] [Related]
16. The synergic effect of BRAF
Qu HJ; Qu XY; Hu Z; Lin Y; Wang JR; Zheng CF; Tan Z
Endocr J; 2018 Jan; 65(1):113-120. PubMed ID: 29070763
[TBL] [Abstract][Full Text] [Related]
17. A nomogram model based on the preoperative clinical characteristics of papillary thyroid carcinoma with Hashimoto's thyroiditis to predict central lymph node metastasis.
Zhao W; He L; Zhu J; Su A
Clin Endocrinol (Oxf); 2021 Feb; 94(2):310-321. PubMed ID: 32984984
[TBL] [Abstract][Full Text] [Related]
18. How Many Contralateral Carcinomas in Patients with Unilateral Papillary Thyroid Microcarcinoma are Preoperatively Misdiagnosed as Benign?
Wu ZG; Yan XQ; Su RS; Ma ZS; Xie BJ; Cao FL
World J Surg; 2017 Jan; 41(1):129-135. PubMed ID: 27541032
[TBL] [Abstract][Full Text] [Related]
19. A Nomogram Based on Clinical and Ultrasound Characteristics to Predict Central Lymph Node Metastasis of Papillary Thyroid Carcinoma.
Feng JW; Hong LZ; Wang F; Wu WX; Hu J; Liu SY; Jiang Y; Ye J
Front Endocrinol (Lausanne); 2021; 12():666315. PubMed ID: 33995284
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for central lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study.
Du J; Yang Q; Sun Y; Shi P; Xu H; Chen X; Dong T; Shi W; Wang Y; Song Z; Shang X; Tian X
Front Endocrinol (Lausanne); 2023; 14():1288527. PubMed ID: 38047112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
